Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 2 (1)

Trial Status

Not Yet Recruiting2
Withdrawn1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07550218Not Yet RecruitingPrimary

Surfactant Administration Methods in Preterm Infants With RDS: A Swedish Cohort Study

NCT07377955Not ApplicableNot Yet RecruitingPrimary

Combined Oscillation-Volume guarantEe Study

NCT02190799Phase 2WithdrawnPrimary

Anti-MERS-CoV Convalescent Plasma Therapy

Showing all 3 trials

Research Network

Activity Timeline